期刊
CURRENT OPINION IN OPHTHALMOLOGY
卷 22, 期 3, 页码 166-173出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/ICU.0b013e3283459826
关键词
central serous chorioretinopathy; review; treatment
Purpose of review Greater understanding of central serous chorioretinopathy (CSCR) has changed initial beliefs that CSCR is a benign condition affecting young men with almost complete resolution. CSCR has a spectrum of presentations with more diffuse retinal dysfunction and variations between races. CSCR can affect older individuals and in a subset of patients may lead to significant ocular morbidity. Recent findings Advances in imaging, particularly in indocyanine green angiography and optical coherence tomography, have led to a greater understanding of the pathophysiology of this condition. Treatments for CSCR are still evolving, in particular photodynamic dynamic therapy using lower doses and reduced fluence showing promising results. More research is required on ideal dosage. Anti-vascular endothelial growth factor treatment offers a new medical treatment modality with promising results. Summary There have been recent imaging developments in addition to therapeutic advances for refractory CSCR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据